Applied StemCell Inc.

2:00 PM - 2:15 PM, Tuesday, June 4, 2019 ・ Theater 3
Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered in Milpitas, California. Our goal is to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry. Using our TARGATT™ technology, a gene-of-interest can be specifically inserted at a well-characterized, transcriptionally active locus in the genome with guaranteed transgene expression. This site-specific Knock-in technology has been first established in mouse models, and we have successfully applied it to human cell lines. We are moving forward to various projects that will combine the CRISPR/Cas9 technology and TARGATT™ for highly specified transgene expression. are characterized by high genetic penetrance. Our therapeutic pipeline will have a strong focus on monogenic blood disorders that are characterized by high genetic penetrance Such diseases are a strong point for the company, which specializes in the genetic engineering of stem cell lineages.
Ticker:
Not Provided.
Exchange:
Not Provided.
Company Type:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2008
Main Therapeutic Focus:
Lead Product in Development:
Under Development
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Speaker
photo
CSO
Applied StemCell